# Repairogen Corp. — Form D

Repairogen Corp. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-03. The offering totals $465K, of which $115K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-01-03
- Form: D
- Accession: 0001595709-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $465K
- Amount sold: $115K
- Remaining: $350K
- Investors: 6
- Date of first sale: 2013-12-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-209202

## Issuer

- Name: Repairogen Corp.
- CIK: 0001595709
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 345 EAST 80TH STREET, NEW YORK, NY, 10075
- Phone: 240-988-2558

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Michael Boice | Director | New York, NY |
| Frank Borchetta | Director | New York, NY |
| Michael Boice | Executive Officer | New York, NY |
| Frank Borchetta | Executive Officer | New York, NY |

## More

- [CIK 1595709 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1595709&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001595709-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.